Automated SPE and nanoLC–MS analysis of somatostatin

References

• Bakhit, C.; Koda, L.; Benoit, R.; Morrison, J. H.; Bloom, F. E. Evidence for Selective Release of Somatostatin-14 and Somatostatin-28(1–12) from Rat Hypothalamus. J. Neurosci. 1984, 4, 411–419.
   PubMed Web of Science ®Google Scholar
• Basivireddy, J.; Somvanshi, R. K.; Romero, I. A.; Weksler, B. B.; Couraud, P. O.; Oger, J.; Kumar, U. Somatostatin Preserved Blood Brain Barrier Against Cytokine Induced Alterations: Possible Role in Multiple Sclerosis. Biochem. Pharmacol. 2013, 86, 497–507.
   PubMed Web of Science ®Google Scholar
• Bladergroen, M. R.; Derks, R. J. E.; Nicolardi, S.; de Visser, B.; van Berloo, S.; van der Burgt, Y. E. M.; Deelder, A. M. Standardized and Automated Solid-phase Extraction Procedures for High-throughput Proteomics of Body Fluids. J. Proteomics 2012, 77, 144–153.
   PubMed Web of Science ®Google Scholar
• Brown, M. R.; Rivier, C.; Vale, W. Central Nervous-system Regulation of Adrenocorticotropin Secretion—Role of Somatostatins. Endocrinology 1984, 114, 1546–1549.
   PubMed Web of Science ®Google Scholar
• Burgos-Ramos, E.; Hervas-Aguilar, A.; Aguado-Llera, D.; Puebla-Jimenez, L.; Hernandez-Pinto, A. M.; Barrios, V.; Arilla-Ferreiro, E. Somatostatin and Alzheimer’s Disease. Mol. Cell. Endocrinol. 2008, 286, 104–111.
   PubMed Web of Science ®Google Scholar
• Calderon-Santiago, M.; Mata-Granados, J. M.; Priego-Capote, F.; Quesada-Gomez, J. M.; de Castro, M. D. L. Analytical Platform for Verification and Quantitation of Target Peptides in Human Serum: Application to Cathelicidin. Anal. Biochem. 2011, 415, 39–45.
   PubMed Web of Science ®Google Scholar
• Chatterjee, S.; Vrolix, G.; Depoortere, I.; Peeters, T.; Van Marck, E. The Therapeutic Effect of the Neuropeptide Hormone Somatostatin on Schistosoma mansoni Caused Liver Fibrosis. BMC Infect. Dis. 2005, 5, 45.
   PubMed Web of Science ®Google Scholar
• den Bosch, J. V.; Adriaensen, D.; Van Nassauw, L.; Timmermans, J. P. The Role(s) of Somatostatin, Structurally Related Peptides and Somatostatin Receptors in the Gastrointestinal Tract: A Review. Regul. Pept. 2009, 156, 1–8.
   PubMedGoogle Scholar
• Dillen, L.; Cools, W.; Vereyken, L.; Lorreyne, W.; Huybrechts, T.; de Vries, R.; Ghobarah, H.; Cuyckens, F. Comparison of Triple Quadrupole and High-resolution TOF–MS for Quantification of Peptides. Bioanalysis 2012, 4, 565–579.
   PubMed Web of Science ®Google Scholar
• Dillen, L.; Cuyckens, F. High-resolution MS: First Choice for Peptide Quantification? Bioanalysis 2013, 5, 1145–1148.
   PubMed Web of Science ®Google Scholar
• Epelbaum, J.; Ruberg, M.; Moyse, E.; Javoy-Agid, F.; Dubois, B.; Agid, Y. Somatostatin and Dementia in Parkinson’s Disease. Brain Res. 1983, 278, 376–379.
   PubMed Web of Science ®Google Scholar
• Franz, T.; Li, X. The OASIS(R) HLB muElution Plate as a One-step Platform for Manual High-throughput In-gel Digestion of Proteins and Peptide Desalting. Proteomics 2012, 12, 2487–2492.
   PubMed Web of Science ®Google Scholar
• Gilar, M.; Xie, H. W.; Jaworski, A. Utility of Retention Prediction Model for Investigation of Peptide Separation Selectivity in Reversed-phase Liquid Chromatography: Impact of Concentration of Trifluoroacetic Acid, Column Temperature, Gradient Slope and Type of Stationary Phase. Anal. Chem. 2010, 82, 265–275.
   PubMed Web of Science ®Google Scholar
• Harrison, A. C.; Walker, D. K. Automated 96-well Solid Phase Extraction for the Determination of Doramectin in Cattle Plasma. J. Pharm. Biomed. Anal. 1998, 16, 777–783.
   PubMed Web of Science ®Google Scholar
• Houbart, V.; Rozet, E.; Matagne, A.; Crommen, J.; Servais, A. C.; Fillet, M. Influence of Sample and Mobile Phase Composition on Peptide Retention Behaviour and Sensitivity in Reversed-phase Liquid Chromatography/Mass Spectrometry. J. Chromatogr. A 2013, 1314, 199–207.
   PubMed Web of Science ®Google Scholar
• Jagerdeo, E.; Montgomery, M. A.; Karas, R. P.; Sibum, M. A Fast Method for Screening and/or Quantitation of Tetrahydrocannabinol and Metabolites in Urine by Automated SPE/LC/MS/MS. Anal. Bioanal. Chem. 2010, 398, 329–338.
   PubMed Web of Science ®Google Scholar
• Johnsen, E.; Leknes, S.; Wilson, S. R.; Lundanes, E. Liquid Chromatography–Mass Spectrometry Platform for Both Small Neurotransmitters and Neuropeptides in Blood, with Automatic and Robust Solid Phase Extraction. Sci. Rep. 2015, 5, 9308.
   PubMed Web of Science ®Google Scholar
• Kay, R. G.; Roberts, A. Bioanalysis of Biotherapeutic Proteins and Peptides: Immunological or MS Approach? Bioanalysis 2012, 4, 857–860.
   PubMed Web of Science ®Google Scholar
• Konradi, C.; Yang, C. K.; Zimmerman, E. I.; Lohmann, K. M.; Gresch, P.; Pantazopoulos, H.; Berretta, S.; Heckers, S. Hippocampal Interneurons are Abnormal in Schizophrenia. Schizophr. Res. 2011, 131, 165–173.
   PubMed Web of Science ®Google Scholar
• Kovac, S.; Walker, M. C. Neuropeptides in Epilepsy. Neuropeptides 2013, 47, 467–475.
   PubMed Web of Science ®Google Scholar
• Leidy, J. W.; Daniels, K. L.; Millard, W. J. Solid-phase Radioimmunoassay and Chemiluminoimmunoassay for Somatostatin in Unextracted Rat Plasma. J. Neurosci. Methods 1996, 68, 7–13.
   PubMed Web of Science ®Google Scholar
• Maasz, G.; Pirger, Z.; Reglodi, D.; Petrovics, D.; Schmidt, J.; Kiss, P.; Rivnyak, A.; Hashimoto, H.; Avar, P.; Jambor, E.; Tamas, A.; Gaszner, B.; Mark, L. Comparative Protein Composition of the Brains of PACAP-Deficient Mice Using Mass Spectrometry-based Proteomic Analysis. Journal of Molecular Neuroscience 2014, 54, 310–319.
   PubMed Web of Science ®Google Scholar
• Masongarcia, M.; Vaccarella, M.; Horvath, J.; Redding, T. W.; Groot, K.; Orsolini, P.; Schally, A. V. Radioimmunoassay for Octapeptide Analogs of Somatostatin—Measurement of Serum Levels After Administration of Long-acting Microcapsule Formulations. Proc. Natl. Acad. Sci. USA 1988, 85, 5688–5692.
   PubMed Web of Science ®Google Scholar
• Nemeth, J.; Helyes, Z.; Gorcs, T.; Gardi, J.; Pinter, E.; Szolcsanyi, J. Development of Somatostatin Radioimmunoassay for the Measurement of Plasma and Tissue Contents of Hormone. Acta Physiol. Hung. 1996, 84, 313–315.
   PubMedGoogle Scholar
• Nilsson, A.; Stroth, N.; Zhang, X. Q.; Qi, H. S.; Falth, M.; Skold, K.; Hoyer, D.; Andren, P. E.; Svenningsson, P. Neuropeptidomics of Mouse Hypothalamus After Imipramine Treatment Reveal Somatostatin as a Potential Mediator of Antidepressant Effects. Neuropharmacology 2012, 62, 347–357.
   PubMed Web of Science ®Google Scholar
• Nilsson, C.; Westman, A.; Blennow, K.; Ekman, R. Processing of Neuropeptide Y and Somatostatin in Human Cerebrospinal Fluid as Monitored by Radioimmunoassay and Mass Spectrometry. Peptides 1998, 19, 1137–1146.
   PubMed Web of Science ®Google Scholar
• Pinter, E.; Helyes, Z.; Szolcsanyi, J. Inhibitory Effect of Somatostatin on Inflammation and Nociception. Pharmacol. Ther. 2006, 112, 440–456.
   PubMed Web of Science ®Google Scholar
• Suehiro, Y.; Yasuda, A.; Okuyama, T.; Imada, H.; Kuroyanagi, Y.; Kubo, T.; Takeuchi, H. Mass Spectrometric Map of Neuropeptide Expression and Analysis of the Gamma-prepro-tachykinin Gene Expression in the Medaka (Oryzias latipes) Brain. Gen. Comp. Endocrinol. 2009, 161, 138–145.
   PubMed Web of Science ®Google Scholar
• Tong, X. C. S.; Wang, J. Y.; Zheng, S.; Pivnichny, J. V. High-throughput Pharmacokinetics Screen of VLA-4 Antagonists by LC/MS/MS Coupled with Automated Solid-phase Extraction Sample Preparation. J. Pharm. Biomed. Anal. 2004, 35, 867–877.
   PubMed Web of Science ®Google Scholar
• Van Eeckhaut, A.; Mangelings, D. Toward Greener Analytical Techniques for the Absolute Quantification of Peptides in Pharmaceutical and Biological Samples. J. Pharm. Biomed. Anal. 2015, 113, 181–188.
   PubMed Web of Science ®Google Scholar